Annual Short Term Debt
$22.50 K
-$6.44 M-99.65%
01 December 2023
Summary:
Altamira Therapeutics annual short term debt is currently $22.50 thousand, with the most recent change of -$6.44 million (-99.65%) on 01 December 2023. During the last 3 years, it has fallen by -$577.20 thousand (-96.25%). CYTO annual short term debt is now -99.85% below its all-time high of $15.45 million, reached on 31 December 2013.CYTO Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$123.40 K
+$100.90 K+448.44%
01 June 2024
Summary:
Altamira Therapeutics quarterly short term debt is currently $123.40 thousand, with the most recent change of +$100.90 thousand (+448.44%) on 01 June 2024. Over the past year, it has dropped by -$2.38 million (-95.06%). CYTO quarterly short term debt is now -99.20% below its all-time high of $15.45 million, reached on 31 December 2013.CYTO Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTO Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -99.7% | -95.1% |
| 3 y3 years | -96.3% | - |
| 5 y5 years | -98.5% | - |
CYTO Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -99.7% | at low | -98.1% | +448.4% |
| 5 y | 5 years | -99.7% | at low | -98.1% | +448.4% |
| alltime | all time | -99.8% | at low | -99.2% | +448.4% |
Altamira Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $123.40 K(+448.4%) |
| Dec 2023 | $22.50 K(-99.7%) | $22.50 K(-99.1%) |
| June 2023 | - | $2.50 M(-61.3%) |
| Dec 2022 | $6.46 M(+5066.6%) | $6.46 M(+27.9%) |
| June 2022 | - | $5.05 M(+3938.7%) |
| Dec 2021 | $125.00 K(-79.2%) | $125.00 K(-79.2%) |
| Dec 2020 | $599.70 K(-58.9%) | $599.70 K(-58.9%) |
| Dec 2018 | $1.46 M | $1.46 M(-33.3%) |
| Sept 2018 | - | $2.19 M(-39.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | - | $3.63 M(-18.2%) |
| Mar 2018 | - | $4.43 M(-4.9%) |
| Dec 2017 | $4.66 M(+114.7%) | $4.66 M(+3.1%) |
| Sept 2017 | - | $4.52 M(+1.1%) |
| June 2017 | - | $4.47 M(+35.8%) |
| Mar 2017 | - | $3.29 M(+51.6%) |
| Dec 2016 | $2.17 M(-85.9%) | $2.17 M(+101.3%) |
| Sept 2016 | - | $1.08 M(-93.0%) |
| Dec 2013 | $15.45 M | $15.45 M |
FAQ
- What is Altamira Therapeutics annual short term debt?
- What is the all time high annual short term debt for Altamira Therapeutics?
- What is Altamira Therapeutics annual short term debt year-on-year change?
- What is Altamira Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Altamira Therapeutics?
- What is Altamira Therapeutics quarterly short term debt year-on-year change?
What is Altamira Therapeutics annual short term debt?
The current annual short term debt of CYTO is $22.50 K
What is the all time high annual short term debt for Altamira Therapeutics?
Altamira Therapeutics all-time high annual short term debt is $15.45 M
What is Altamira Therapeutics annual short term debt year-on-year change?
Over the past year, CYTO annual short term debt has changed by -$6.44 M (-99.65%)
What is Altamira Therapeutics quarterly short term debt?
The current quarterly short term debt of CYTO is $123.40 K
What is the all time high quarterly short term debt for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly short term debt is $15.45 M
What is Altamira Therapeutics quarterly short term debt year-on-year change?
Over the past year, CYTO quarterly short term debt has changed by -$2.38 M (-95.06%)